Literature DB >> 6407049

The role of brain norepinephrine in clonidine suppression of isolation-induced distress in the domestic chick.

J Rossi, T L Sahley, J Panksepp.   

Abstract

Distress vocalizations (DV) induced by social isolation were measured in 1-day-old domestic chicks after intracerebroventricular injections of drugs believed to exert their effects through the noradrenergic system. The alpha-adrenoreceptor agonist clonidine reliably suppressed DV rates at doses low as 0.08 micrograms. When given alone, phentolamine, phenoxybenzamine, propranolol, sotalol, and yohimbine (adrenoreceptor antagonists) did not reliably alter DV rates at doses that were not toxic. The clonidine DV suppression was reliably reversed by yohimbine (1.75 micrograms), but by none of the other adrenoceptor antagonists or naloxone. 6-Hydroxydopamine at doses as high as 120 micrograms, which essentially eliminated forebrain norepinephrine, failed to suppress DV rates reliably when given alone and, when given in combination with clonidine (0.1 micrograms) or morphine (0.05 micrograms), failed to reverse the severe DV suppression imposed by these drugs. The results suggest that clonidine suppresses DV rates in or by some means other than prejunctional alpha 2-adrenoreceptor stimulation.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407049     DOI: 10.1007/BF00433414

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  24 in total

1.  Effects of clonidine on morphine withdrawal signs in the rat.

Authors:  L F Tseng; H H Loh; E T Wei
Journal:  Eur J Pharmacol       Date:  1975-01       Impact factor: 4.432

2.  Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.

Authors:  M S Gold; D E Redmond; H D Kleber
Journal:  Am J Psychiatry       Date:  1979-01       Impact factor: 18.112

3.  Catecholamine receptors on locus coeruleus neurons: pharmacological characterization.

Authors:  J M Cedarbaum; G K Aghajanian
Journal:  Eur J Pharmacol       Date:  1977-08-15       Impact factor: 4.432

4.  Involvement of alpha-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones.

Authors:  K Starke; H Montel
Journal:  Neuropharmacology       Date:  1973-11       Impact factor: 5.250

5.  The influence of imipramine on the "abstinence syndrome" to morphine in mice.

Authors:  L Chiosa; S Dumitrescu; A Banaru
Journal:  Int J Neuropharmacol       Date:  1968-03

6.  Method for the rapid determination of norepinephrine, dopamine, and serotonin in the same brain region.

Authors:  D M Jacobowitz; J S Richardson
Journal:  Pharmacol Biochem Behav       Date:  1978-05       Impact factor: 3.533

7.  Clonidine reverses the increased norepinephrine turnover during morphine withdrawal in rats.

Authors:  R Laverty; R H Roth
Journal:  Brain Res       Date:  1980-01-27       Impact factor: 3.252

8.  Reduction of distress vocalization in chicks by opiate-like peptides.

Authors:  J Panksepp; T Vilberg; N J Bean; D H Coy; A J Kastin
Journal:  Brain Res Bull       Date:  1978 Nov-Dec       Impact factor: 4.077

9.  The biology of social attachments: opiates alleviate separation distress.

Authors:  J Panksepp; B Herman; R Conner; P Bishop; J P Scott
Journal:  Biol Psychiatry       Date:  1978-10       Impact factor: 13.382

10.  Effects of morphine and naloxone on separation distress and approach attachment: evidence for opiate mediation of social affect.

Authors:  B H Herman; J Panksepp
Journal:  Pharmacol Biochem Behav       Date:  1978-08       Impact factor: 3.533

View more
  2 in total

1.  Brain opioids and autism: an updated analysis of possible linkages.

Authors:  T L Sahley; J Panksepp
Journal:  J Autism Dev Disord       Date:  1987-06

2.  Effects of alpha-2 adrenoceptor antagonists on rough-and-tumble play in juvenile rats: evidence for a site of action independent of non-adrenoceptor imidazoline binding sites.

Authors:  S M Siviy; A E Fleischhauer; S J Kuhlman; D M Atrens
Journal:  Psychopharmacology (Berl)       Date:  1994-01       Impact factor: 4.530

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.